LIVER CIRRHOSIS: ETIOLOGY, PATHOGENESIS AND MODERN MANAGEMENT
Keywords:
Liver Cirrhosis, Hepatic Fibrosis, Portal Hypertension, Ascites, Hepatocellular Carcinoma, Chronic Hepatitis, Alcoholic Liver Disease, Liver Failure, Esophageal Varices, MELD ScoreAbstract
Liver cirrhosis is a chronic, progressive liver disease characterized by diffuse fibrosis, regenerative nodule formation, and distortion of normal hepatic architecture. It represents the final stage of many chronic liver disorders and is associated with high morbidity and mortality worldwide. This study analyzes the etiology, pathogenesis, clinical manifestations, diagnostic approaches, complications, and contemporary management strategies of liver cirrhosis using the IMRAD structure and evidence-based guidelines.
References
1. European Association for the Study of the Liver (EASL). (2022). Clinical Practice Guidelines on Liver Cirrhosis.
2. American Association for the Study of Liver Diseases (AASLD). (2023). Practice Guidance for Cirrhosis Management.
3. Asrani SK, et al. (2019). Burden of liver diseases in the world. Journal of Hepatology.
4. Garcia-Tsao G, et al. (2017). Portal hypertensive bleeding in cirrhosis. Hepatology.
5. Bosch J, et al. (2015). Portal hypertension. The Lancet.
6. Tapper EB, Parikh ND. (2018). Mortality due to cirrhosis. Gastroenterology.
7. WHO. (2023). Global Hepatitis Report.
